APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Subcontractor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drug Subcontractor Industry Growth and Trends Forecast to 2032

3 May 2026104 pages

Choose your research edition.

Industry ResearchDrug Subcontractor Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Subcontractor Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Drug Subcontractor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Subcontractor Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Subcontractor Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Drug Subcontractor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drug Subcontractor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drug Subcontractor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Subcontractor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug Subcontractor include JVM, Takazono Corporation, TOSHO, JHNT, SANYO, Cretem, Allon Technology, Yuyama Manufacturing and Beijing Huakangxin Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drug Subcontractor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drug Subcontractor market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Subcontractor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Subcontractor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Drug Subcontractor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drug Subcontractor Market by Company

JVM

Takazono Corporation

TOSHO

JHNT

SANYO

Cretem

Allon Technology

Yuyama Manufacturing

Beijing Huakangxin Medical

Suzhou Huisiteng

Shanghai Qiyou Precision Mechanical and Electrical

Jiangsu Fowa Medical

Drug Subcontractor Segment by Type

Fully-automatic

Semi-automatic

Drug Subcontractor Segment by Application

Private Hospital

Public Hospital

Drug Subcontractor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Subcontractor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Subcontractor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Subcontractor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drug Subcontractor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Drug Subcontractor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Fully-automatic Table 2. Major Company of Semi-automatic Table 3. Global Drug Subcontractor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Drug Subcontractor Sales by Type (2021-2026) & (units) Table 5. Global Drug Subcontractor Sales Market Share in Volume by Type (2021-2026) Table 6. Global Drug Subcontractor Sales by Type (2021-2026) & (US$ Million) Table 7. Global Drug Subcontractor Sales Market Share in Value by Type (2021-2026) Table 8. Global Drug Subcontractor Price by Type (2021-2026) & (USD/unit) Table 9. Global Drug Subcontractor Sales by Type (2027-2032) & (units) Table 10. Global Drug Subcontractor Sales Market Share in Volume by Type (2027-2032) Table 11. Global Drug Subcontractor Sales by Type (2027-2032) & (US$ Million) Table 12. Global Drug Subcontractor Sales Market Share in Value by Type (2027-2032) Table 13. Global Drug Subcontractor Price by Type (2027-2032) & (USD/unit) Table 14. North America Drug Subcontractor Sales by Type (2021-2026) & (units) Table 15. North America Drug Subcontractor Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Drug Subcontractor Sales by Type (2021-2026) & (units) Table 17. Europe Drug Subcontractor Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Drug Subcontractor Sales by Type (2021-2026) & (units) Table 19. Asia-Pacific Drug Subcontractor Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Drug Subcontractor Sales by Type (2021-2026) & (units) Table 21. Latin America Drug Subcontractor Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Drug Subcontractor Sales by Type (2021-2026) & (units) Table 23. Middle East and Africa Drug Subcontractor Sales by Type (2021-2026) & (US$ Million) Table 24. Drug Subcontractor Industry Trends Table 25. Drug Subcontractor Industry Drivers Table 26. Drug Subcontractor Industry Opportunities and Challenges Table 27. Drug Subcontractor Industry Restraints Table 28. Global Drug Subcontractor Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Drug Subcontractor Revenue Market Share by Company (2021-2026) Table 30. Global Drug Subcontractor Sales by Company (2021-2026) & (units) Table 31. Global Drug Subcontractor Sales Share by Company (2021-2026) Table 32. Global Drug Subcontractor Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Drug Subcontractor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Drug Subcontractor Major Company Production Sites and Headquarters Table 35. Global Drug Subcontractor Company, Product Type & Application Table 36. Global Drug Subcontractor Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Drug Subcontractor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Drug Subcontractor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Drug Subcontractor Sales by Region (2021-2026) & (units) Table 41. Global Drug Subcontractor Sales Market Share in Volume by Region (2021-2026) Table 42. Global Drug Subcontractor Sales by Region (2021-2026) & (US$ Million) Table 43. Global Drug Subcontractor Sales Market Share in Value by Region (2021-2026) Table 44. Global Drug Subcontractor Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Drug Subcontractor Sales by Region (2027-2032) & (units) Table 46. Global Drug Subcontractor Sales Market Share in Volume by Region (2027-2032) Table 47. Global Drug Subcontractor Sales by Region (2027-2032) & (US$ Million) Table 48. Global Drug Subcontractor Sales Market Share in Value by Region (2027-2032) Table 49. Global Drug Subcontractor Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Drug Subcontractor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Drug Subcontractor Sales by Application (2021-2026) & (units) Table 52. Global Drug Subcontractor Sales Market Share in Volume by Application (2021-2026) Table 53. Global Drug Subcontractor Sales by Application (2021-2026) & (US$ Million) Table 54. Global Drug Subcontractor Sales Market Share in Value by Application (2021-2026) Table 55. Global Drug Subcontractor Price by Application (2021-2026) & (USD/unit) Table 56. Global Drug Subcontractor Sales by Application (2027-2032) & (units) Table 57. Global Drug Subcontractor Sales Market Share in Volume by Application (2027-2032) Table 58. Global Drug Subcontractor Sales by Application (2027-2032) & (US$ Million) Table 59. Global Drug Subcontractor Sales Market Share in Value by Application (2027-2032) Table 60. Global Drug Subcontractor Price by Application (2027-2032) & (USD/unit) Table 61. North America Drug Subcontractor Sales by Application (2021-2026) & (units) Table 62. North America Drug Subcontractor Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Drug Subcontractor Sales by Application (2021-2026) & (units) Table 64. Europe Drug Subcontractor Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Drug Subcontractor Sales by Application (2021-2026) & (units) Table 66. Asia-Pacific Drug Subcontractor Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Drug Subcontractor Sales by Application (2021-2026) & (units) Table 68. Latin America Drug Subcontractor Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Drug Subcontractor Sales by Application (2021-2026) & (units) Table 70. Middle East and Africa Drug Subcontractor Sales by Application (2021-2026) & (US$ Million) Table 71. JVM Company Information Table 72. JVM Business Overview Table 73. JVM Drug Subcontractor Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. JVM Drug Subcontractor Product Portfolio Table 75. JVM Recent Development Table 76. Takazono Corporation Company Information Table 77. Takazono Corporation Business Overview Table 78. Takazono Corporation Drug Subcontractor Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Takazono Corporation Drug Subcontractor Product Portfolio Table 80. Takazono Corporation Recent Development Table 81. TOSHO Company Information Table 82. TOSHO Business Overview Table 83. TOSHO Drug Subcontractor Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. TOSHO Drug Subcontractor Product Portfolio Table 85. TOSHO Recent Development Table 86. JHNT Company Information Table 87. JHNT Business Overview Table 88. JHNT Drug Subcontractor Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. JHNT Drug Subcontractor Product Portfolio Table 90. JHNT Recent Development Table 91. SANYO Company Information Table 92. SANYO Business Overview Table 93. SANYO Drug Subcontractor Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. SANYO Drug Subcontractor Product Portfolio Table 95. SANYO Recent Development Table 96. Cretem Company Information Table 97. Cretem Business Overview Table 98. Cretem Drug Subcontractor Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Cretem Drug Subcontractor Product Portfolio Table 100. Cretem Recent Development Table 101. Allon Technology Company Information Table 102. Allon Technology Business Overview Table 103. Allon Technology Drug Subcontractor Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Allon Technology Drug Subcontractor Product Portfolio Table 105. Allon Technology Recent Development Table 106. Yuyama Manufacturing Company Information Table 107. Yuyama Manufacturing Business Overview Table 108. Yuyama Manufacturing Drug Subcontractor Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Yuyama Manufacturing Drug Subcontractor Product Portfolio Table 110. Yuyama Manufacturing Recent Development Table 111. Beijing Huakangxin Medical Company Information Table 112. Beijing Huakangxin Medical Business Overview Table 113. Beijing Huakangxin Medical Drug Subcontractor Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Beijing Huakangxin Medical Drug Subcontractor Product Portfolio Table 115. Beijing Huakangxin Medical Recent Development Table 116. Suzhou Huisiteng Company Information Table 117. Suzhou Huisiteng Business Overview Table 118. Suzhou Huisiteng Drug Subcontractor Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Suzhou Huisiteng Drug Subcontractor Product Portfolio Table 120. Suzhou Huisiteng Recent Development Table 121. Shanghai Qiyou Precision Mechanical and Electrical Company Information Table 122. Shanghai Qiyou Precision Mechanical and Electrical Business Overview Table 123. Shanghai Qiyou Precision Mechanical and Electrical Drug Subcontractor Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Shanghai Qiyou Precision Mechanical and Electrical Drug Subcontractor Product Portfolio Table 125. Shanghai Qiyou Precision Mechanical and Electrical Recent Development Table 126. Jiangsu Fowa Medical Company Information Table 127. Jiangsu Fowa Medical Business Overview Table 128. Jiangsu Fowa Medical Drug Subcontractor Sales (units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Jiangsu Fowa Medical Drug Subcontractor Product Portfolio Table 130. Jiangsu Fowa Medical Recent Development Table 131. North America Drug Subcontractor Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 132. North America Drug Subcontractor Sales by Country (2021-2026) & (units) Table 133. North America Drug Subcontractor Sales Market Share by Country (2021-2026) Table 134. North America Drug Subcontractor Sales Forecast by Country (2027-2032) & (units) Table 135. North America Drug Subcontractor Sales Market Share Forecast by Country (2027-2032) Table 136. North America Drug Subcontractor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Drug Subcontractor Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Drug Subcontractor Market Share by Country (2021-2026) Table 139. North America Drug Subcontractor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Drug Subcontractor Market Share Forecast by Country (2027-2032) Table 141. Europe Drug Subcontractor Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 142. Europe Drug Subcontractor Sales by Country (2021-2026) & (units) Table 143. Europe Drug Subcontractor Sales Market Share by Country (2021-2026) Table 144. Europe Drug Subcontractor Sales Forecast by Country (2027-2032) & (units) Table 145. Europe Drug Subcontractor Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Drug Subcontractor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Drug Subcontractor Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Drug Subcontractor Market Share by Country (2021-2026) Table 149. Europe Drug Subcontractor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Drug Subcontractor Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Drug Subcontractor Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Drug Subcontractor Sales by Country (2021-2026) & (units) Table 153. Asia-Pacific Drug Subcontractor Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Drug Subcontractor Sales Forecast by Country (2027-2032) & (units) Table 155. Asia-Pacific Drug Subcontractor Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Drug Subcontractor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Drug Subcontractor Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Drug Subcontractor Market Share by Country (2021-2026) Table 159. Asia-Pacific Drug Subcontractor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Drug Subcontractor Market Share Forecast by Country (2027-2032) Table 161. Latin America Drug Subcontractor Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 162. Latin America Drug Subcontractor Sales by Country (2021-2026) & (units) Table 163. Latin America Drug Subcontractor Sales Market Share by Country (2021-2026) Table 164. Latin America Drug Subcontractor Sales Forecast by Country (2027-2032) & (units) Table 165. Latin America Drug Subcontractor Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Drug Subcontractor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Drug Subcontractor Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Drug Subcontractor Market Share by Country (2021-2026) Table 169. Latin America Drug Subcontractor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Drug Subcontractor Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Drug Subcontractor Market Size Growth Rate (CAGR) by Country (units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Drug Subcontractor Sales by Country (2021-2026) & (units) Table 173. Middle East and Africa Drug Subcontractor Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Drug Subcontractor Sales Forecast by Country (2027-2032) & (units) Table 175. Middle East and Africa Drug Subcontractor Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Drug Subcontractor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Drug Subcontractor Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Drug Subcontractor Market Share by Country (2021-2026) Table 179. Middle East and Africa Drug Subcontractor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Drug Subcontractor Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Drug Subcontractor Distributors List Table 184. Drug Subcontractor Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Drug Subcontractor Image Figure 2. Global Drug Subcontractor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Subcontractor Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Subcontractor Sales (2021-2032) & (units) Figure 5. Fully-automatic Image Figure 6. Global Fully-automatic Sales YoY Growth (2021-2032) & (units) Figure 7. Semi-automatic Image Figure 8. Global Semi-automatic Sales YoY Growth (2021-2032) & (units) Figure 9. Global Drug Subcontractor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Drug Subcontractor Market Share by Type 2025 VS 2032 Figure 11. North America Drug Subcontractor Sales Market Share in Volume by Type in 2025 Figure 12. North America Drug Subcontractor Sales Market Share in Value by Type in 2025 Figure 13. Europe Drug Subcontractor Sales Market Share in Volume by Type in 2025 Figure 14. Europe Drug Subcontractor Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Drug Subcontractor Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Drug Subcontractor Sales Market Share in Value by Type in 2025 Figure 17. Latin America Drug Subcontractor Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Drug Subcontractor Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Drug Subcontractor Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Drug Subcontractor Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Drug Subcontractor Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Private Hospital Image Figure 24. Global Private Hospital Sales YoY Growth (2021-2032) & (units) Figure 25. Public Hospital Image Figure 26. Global Public Hospital Sales YoY Growth (2021-2032) & (units) Figure 27. Global Drug Subcontractor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Drug Subcontractor Market Share by Application 2025 VS 2032 Figure 29. North America Drug Subcontractor Sales Market Share in Volume by Application in 2025 Figure 30. North America Drug Subcontractor Sales Market Share in Value by Application in 2025 Figure 31. Europe Drug Subcontractor Sales Market Share in Volume by Application in 2025 Figure 32. Europe Drug Subcontractor Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Drug Subcontractor Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Drug Subcontractor Sales Market Share in Value by Application in 2025 Figure 35. Latin America Drug Subcontractor Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Drug Subcontractor Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Drug Subcontractor Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Drug Subcontractor Sales Market Share in Value by Application in 2025 Figure 39. North America Drug Subcontractor Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 40. North America Drug Subcontractor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Drug Subcontractor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Drug Subcontractor Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Drug Subcontractor Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 44. Europe Drug Subcontractor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Drug Subcontractor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Drug Subcontractor Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Drug Subcontractor Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 48. Asia-Pacific Drug Subcontractor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Drug Subcontractor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Drug Subcontractor Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Drug Subcontractor Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 52. Latin America Drug Subcontractor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Drug Subcontractor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Drug Subcontractor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Drug Subcontractor Sales by Country: 2021 VS 2025 VS 2032 (units) Figure 56. Middle East and Africa Drug Subcontractor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Drug Subcontractor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Drug Subcontractor Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Drug Subcontractor Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Drug Subcontractor Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Fully-automatic
  • Semi-automatic
Applications
  • Private Hospital
  • Public Hospital
Companies covered
  • JVM
  • Takazono Corporation
  • TOSHO
  • JHNT
  • SANYO
  • Cretem
  • Allon Technology
  • Yuyama Manufacturing
  • Beijing Huakangxin Medical
  • Suzhou Huisiteng
  • Shanghai Qiyou Precision Mechanical and Electrical
  • Jiangsu Fowa Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Drug Subcontractor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Drug Subcontractor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Drug Subcontractor Market by Type
  6. 1.3.1 Fully-automatic
  7. 1.3.2 Semi-automatic
  8. 1.4 Global Drug Subcontractor Market Size by Type
  9. 1.4.1 Global Drug Subcontractor Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Drug Subcontractor Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Drug Subcontractor Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Drug Subcontractor Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Drug Subcontractor Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Drug Subcontractor Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Drug Subcontractor Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Drug Subcontractor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Drug Subcontractor Industry Trends
  2. 2.2 Drug Subcontractor Industry Drivers
  3. 2.3 Drug Subcontractor Industry Opportunities and Challenges
  4. 2.4 Drug Subcontractor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Drug Subcontractor Revenue (2021-2026)
  2. 3.2 Global Top Players by Drug Subcontractor Sales (2021-2026)
  3. 3.3 Global Top Players by Drug Subcontractor Price (2021-2026)
  4. 3.4 Global Drug Subcontractor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drug Subcontractor Major Company Production Sites & Headquarters
  6. 3.6 Global Drug Subcontractor Company, Product Type & Application
  7. 3.7 Global Drug Subcontractor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drug Subcontractor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drug Subcontractor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drug Subcontractor Tier 1, Tier 2, and Tier 3
4 Drug Subcontractor Regional Status and Outlook
  1. 4.1 Global Drug Subcontractor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Drug Subcontractor Historic Market Size by Region
  3. 4.2.1 Global Drug Subcontractor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Drug Subcontractor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Drug Subcontractor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Drug Subcontractor Forecasted Market Size by Region
  7. 4.3.1 Global Drug Subcontractor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Drug Subcontractor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Drug Subcontractor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Drug Subcontractor by Application
  1. 5.1 Drug Subcontractor Market by Application
  2. 5.1.1 Private Hospital
  3. 5.1.2 Public Hospital
  4. 5.2 Global Drug Subcontractor Market Size by Application
  5. 5.2.1 Global Drug Subcontractor Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Drug Subcontractor Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Drug Subcontractor Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Drug Subcontractor Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Drug Subcontractor Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Drug Subcontractor Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Drug Subcontractor Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Drug Subcontractor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 JVM
  2. 6.1.1 JVM Company Information
  3. 6.1.2 JVM Business Overview
  4. 6.1.3 JVM Drug Subcontractor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 JVM Drug Subcontractor Product Portfolio
  6. 6.1.5 JVM Recent Developments
  7. 6.2 Takazono Corporation
  8. 6.2.1 Takazono Corporation Company Information
  9. 6.2.2 Takazono Corporation Business Overview
  10. 6.2.3 Takazono Corporation Drug Subcontractor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takazono Corporation Drug Subcontractor Product Portfolio
  12. 6.2.5 Takazono Corporation Recent Developments
  13. 6.3 TOSHO
  14. 6.3.1 TOSHO Company Information
  15. 6.3.2 TOSHO Business Overview
  16. 6.3.3 TOSHO Drug Subcontractor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 TOSHO Drug Subcontractor Product Portfolio
  18. 6.3.5 TOSHO Recent Developments
  19. 6.4 JHNT
  20. 6.4.1 JHNT Company Information
  21. 6.4.2 JHNT Business Overview
  22. 6.4.3 JHNT Drug Subcontractor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 JHNT Drug Subcontractor Product Portfolio
  24. 6.4.5 JHNT Recent Developments
  25. 6.5 SANYO
  26. 6.5.1 SANYO Company Information
  27. 6.5.2 SANYO Business Overview
  28. 6.5.3 SANYO Drug Subcontractor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 SANYO Drug Subcontractor Product Portfolio
  30. 6.5.5 SANYO Recent Developments
  31. 6.6 Cretem
  32. 6.6.1 Cretem Company Information
  33. 6.6.2 Cretem Business Overview
  34. 6.6.3 Cretem Drug Subcontractor Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cretem Drug Subcontractor Product Portfolio
  36. 6.6.5 Cretem Recent Developments
  37. 6.7 Allon Technology
  38. 6.7.1 Allon Technology Company Information
  39. 6.7.2 Allon Technology Business Overview
  40. 6.7.3 Allon Technology Drug Subcontractor Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Allon Technology Drug Subcontractor Product Portfolio
  42. 6.7.5 Allon Technology Recent Developments
  43. 6.8 Yuyama Manufacturing
  44. 6.8.1 Yuyama Manufacturing Company Information
  45. 6.8.2 Yuyama Manufacturing Business Overview
  46. 6.8.3 Yuyama Manufacturing Drug Subcontractor Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Yuyama Manufacturing Drug Subcontractor Product Portfolio
  48. 6.8.5 Yuyama Manufacturing Recent Developments
  49. 6.9 Beijing Huakangxin Medical
  50. 6.9.1 Beijing Huakangxin Medical Company Information
  51. 6.9.2 Beijing Huakangxin Medical Business Overview
  52. 6.9.3 Beijing Huakangxin Medical Drug Subcontractor Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Beijing Huakangxin Medical Drug Subcontractor Product Portfolio
  54. 6.9.5 Beijing Huakangxin Medical Recent Developments
  55. 6.10 Suzhou Huisiteng
  56. 6.10.1 Suzhou Huisiteng Company Information
  57. 6.10.2 Suzhou Huisiteng Business Overview
  58. 6.10.3 Suzhou Huisiteng Drug Subcontractor Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Suzhou Huisiteng Drug Subcontractor Product Portfolio
  60. 6.10.5 Suzhou Huisiteng Recent Developments
  61. 6.11 Shanghai Qiyou Precision Mechanical and Electrical
  62. 6.11.1 Shanghai Qiyou Precision Mechanical and Electrical Company Information
  63. 6.11.2 Shanghai Qiyou Precision Mechanical and Electrical Business Overview
  64. 6.11.3 Shanghai Qiyou Precision Mechanical and Electrical Drug Subcontractor Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shanghai Qiyou Precision Mechanical and Electrical Drug Subcontractor Product Portfolio
  66. 6.11.5 Shanghai Qiyou Precision Mechanical and Electrical Recent Developments
  67. 6.12 Jiangsu Fowa Medical
  68. 6.12.1 Jiangsu Fowa Medical Company Information
  69. 6.12.2 Jiangsu Fowa Medical Business Overview
  70. 6.12.3 Jiangsu Fowa Medical Drug Subcontractor Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jiangsu Fowa Medical Drug Subcontractor Product Portfolio
  72. 6.12.5 Jiangsu Fowa Medical Recent Developments
7 North America by Country
  1. 7.1 North America Drug Subcontractor Sales by Country
  2. 7.1.1 North America Drug Subcontractor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Drug Subcontractor Sales by Country (2021-2026)
  4. 7.1.3 North America Drug Subcontractor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Drug Subcontractor Market Size by Country
  6. 7.2.1 North America Drug Subcontractor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Drug Subcontractor Market Size by Country (2021-2026)
  8. 7.2.3 North America Drug Subcontractor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Drug Subcontractor Sales by Country
  2. 8.1.1 Europe Drug Subcontractor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Drug Subcontractor Sales by Country (2021-2026)
  4. 8.1.3 Europe Drug Subcontractor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Drug Subcontractor Market Size by Country
  6. 8.2.1 Europe Drug Subcontractor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Drug Subcontractor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Drug Subcontractor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Drug Subcontractor Sales by Country
  2. 9.1.1 Asia-Pacific Drug Subcontractor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Drug Subcontractor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Drug Subcontractor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Drug Subcontractor Market Size by Country
  6. 9.2.1 Asia-Pacific Drug Subcontractor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Drug Subcontractor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Drug Subcontractor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Drug Subcontractor Sales by Country
  2. 10.1.1 South America Drug Subcontractor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Drug Subcontractor Sales by Country (2021-2026)
  4. 10.1.3 South America Drug Subcontractor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Drug Subcontractor Market Size by Country
  6. 10.2.1 South America Drug Subcontractor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Drug Subcontractor Market Size by Country (2021-2026)
  8. 10.2.3 South America Drug Subcontractor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Drug Subcontractor Sales by Country
  2. 11.1.1 Middle East and Africa Drug Subcontractor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Drug Subcontractor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Drug Subcontractor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Drug Subcontractor Market Size by Country
  6. 11.2.1 Middle East and Africa Drug Subcontractor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Drug Subcontractor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Drug Subcontractor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Drug Subcontractor Value Chain Analysis
  2. 12.1.1 Drug Subcontractor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Drug Subcontractor Production Mode & Process
  7. 12.2 Drug Subcontractor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Drug Subcontractor Distributors
  10. 12.2.3 Drug Subcontractor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst